y*****l
发帖数: 5997 | 1 http://stockcharts.com/scripts/php/candleglance.php?CHTP,ARNA,BIOD,VVUS,BVX,STAA|B|E12,26,9
从图上看，两个减肥药ARNA，VVUS和糖尿病BIOD今天都涨得不错; 低血压CHTP今天下跌
，原因是今天她的帕金森药被FDA通知进一步研究; 两个医疗器械中VVUS图形在底部刚
刚好，BVX还是下跌。欢迎大家补充，老牛和大胖给点药物分析。
12月所有药物FDA：
http://stockcharts.com/scripts/php/candleglance.php?CHTP,CEPH,ARNA,AUXL,BIOD,NVS,NVO,SHPGY,VVUS|B|E12,26,9
Adam的Biotech Calendar:
Chelsea Therapeutics(CHTP Quote)
Drug/indication: Droxidopa for neurogenic orthostatic hypotension
Outcome of FDA meeting to discuss changing primary endpoint of phase III
study: December 2009.
Cephalon(CEPH Quote)
Drug/indication: Nuvigil for jet lag disorder
FDA approval decision date: Dec. 29
Arena Pharmaceuticals(ARNA Quote)
Drug/indication: lorcaserin for obesity
Filing for FDA approval: December 2009
Auxilium Pharmaceuticals(AUXL Quote)
Drug/indication: Xiaflex for Dupuytren's contracture
FDA approval decision date: December 2009
Biodel(BIOD Quote)
Drug/indication: Viaject for diabetes
Filing for FDA approval: December 2009
Novartis(NVS Quote)
Drug/indication: fingolomid for multiple sclerosis
Filing for FDA approval: December 2009
Novo Nordisk(NVO Quote)
Drug/indication: Victoza for diabetes
FDA approval decision date: December 2009
Shire Pharmaceuticals(SHPGY Quote)
Drug/indication: Replagal for Fabry's disease
Filing for FDA approval: December 2009
Vivus(VVUS Quote)
Drug/indication: Qnexa for obesity
Filing for FDA approval: December 2009
医疗器械:
BVX 12/31/09 510(k) BOSS
STAA 12/31/09 sPMA TICL |
|
